Comment
The treatment of WHO Category 1 tuberculosis with 2HRZE/6HE is indeed defensible
Affiliations
- PMID: 10985647
Item in Clipboard
Comment
The treatment of WHO Category 1 tuberculosis with 2HRZE/6HE is indeed defensible
Int J Tuberc Lung Dis.
2000 Sep.
No abstract available
Comment in
-
More on the question of optimal chemotherapy in the presence of isoniazid resistance.Int J Tuberc Lung Dis. 2000 Sep;4(9):890-4. Int J Tuberc Lung Dis. 2000. PMID: 10985663 No abstract available.
Comment on
-
A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.Int J Tuberc Lung Dis. 1997 Dec;1(6):509-17. Int J Tuberc Lung Dis. 1997. PMID: 9487448 Clinical Trial.
-
Is the treatment of WHO category I tuberculosis with 2HRZE/6HE a defensible practice?Int J Tuberc Lung Dis. 1999 Sep;3(9):747-8. Int J Tuberc Lung Dis. 1999. PMID: 10488879 No abstract available.
Similar articles
-
Is the treatment of WHO category I tuberculosis with 2HRZE/6HE a defensible practice?Int J Tuberc Lung Dis. 1999 Sep;3(9):747-8. Int J Tuberc Lung Dis. 1999. PMID: 10488879 No abstract available.
-
More on the question of optimal chemotherapy in the presence of isoniazid resistance.Int J Tuberc Lung Dis. 2000 Sep;4(9):890-4. Int J Tuberc Lung Dis. 2000. PMID: 10985663 No abstract available.
-
A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis.Int J Tuberc Lung Dis. 2008 Sep;12(9):1102; author reply 1102. Int J Tuberc Lung Dis. 2008. PMID: 18713512 No abstract available.
-
Role of individual drugs in the chemotherapy of tuberculosis.Int J Tuberc Lung Dis. 2000 Sep;4(9):796-806. Int J Tuberc Lung Dis. 2000. PMID: 10985648 Review.
-
Tuberculosis.Clin Evid. 2002 Jun;(7):747-56. Clin Evid. 2002. Update in: Clin Evid. 2002 Dec;(8):819-28. PMID: 12230701 Updated. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
